13F-HR filed by Corriente Advisors, LLC
Corriente Advisors, LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 17 holding rows worth $186,162,000.
- Accession
- 0001406718-20-000010
- Filer
- CIK 1406718
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 17 entries on the cover page, a total value of $186,162,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $186,162,000 with VALUE read as thousands by filing date, 13F file number 028-12875. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MAXAR TECHNOLOGIES INC | 57778K105 | COM | 2,682,790 | $42,039,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 192,000 | $39,251,000 | thousands by filing date | |
| VIRGIN GALACTIC HLDGS INC | 92766K106 | COM | 2,411,729 | $27,855,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 252,500 | $18,094,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 285,000 | $17,753,000 | thousands by filing date | |
| INTELSAT S A | L5140P101 | COM | 1,631,227 | $11,468,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 285,000 | $4,524,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 617,084 | $3,647,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 40,000 | $3,180,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 203,898 | $3,038,000 | thousands by filing date | |
| VIRGIN GALACTIC HOLDINGS INC | 92766K114 | W EXP 11/25/202 | 252,983 | $2,922,000 | thousands by filing date | call |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 453,040 | $2,569,000 | thousands by filing date | |
| EQUINOX GOLD CORP | 29446Y502 | COM | 300,000 | $2,307,000 | thousands by filing date | |
| Walt Disney Co | 254687106 | COM | 15,000 | $2,169,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 88,927 | $2,024,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 220,000 | $1,672,000 | thousands by filing date | |
| GOLD FIELDS LTD SPONSORED ADR | 38059T106 | ADR | 250,000 | $1,650,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001406718-20-000010 | this filing | 2020-02-14 | acceptance time not in the bulk data set |